Sigfox Signs A Global Partnership With Skyhook To Improve Delivery of Geolocation Services
Sigfox, a world’s leading IoT (Internet of Things) communication service provider and 0G network pioneer, has announced today its partnership with Skyhook, the leading independent provider of Wi-Fi, cellular, and hybrid positioning. The collaboration is set to improve the quality and performance of existing tracking services on the Sigfox network globally, while delivering enhanced customer experience at an accessible cost.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209005469/en/
As part of its services, Skyhook offers Wi-Fi location solutions, which can be used on its own or as part of a larger hybrid positioning system. This software-based, power-efficient approach uses Wi-Fi, GPS/GNSS, and cellular signals to track location, and uses over 6 billion geolocated Wi-Fi access points, over 110 million geolocated cells, and 1.5 billion geolocated IP addresses for unmatched reliability and accuracy. Through its unique approach, Skyhook’s Precision Location solution is able to accurately locate connected devices anywhere in the world.
By integrating global coverage from Skyhook’s positioning services with Sigfox’s existing Atlas Wi-Fi service, companies will be able to locate their assets in indoor environments, where other positioning methods can fall short. Customers directly benefit from the integration of Skyhook services, removing the need for additional infrastructure, regardless of the size and quantity of assets.
Atlas Wi-Fi, Sigfox’s geolocation service for massive IoT applications is specifically optimized to support global supply chain and logistics applications and combines two technologies and data sources - the Sigfox network and Wi-Fi infrastructure. Accordingly, Sigfox can provide one single location service in all types of geographic environments, without GPS.
Additionally, as Wi-Fi-based location tracking consumes less battery than using GPS, this new partnership will help extend the service life of IoT tracking solutions, thus reducing maintenance costs.
“Skyhook is proud to partner with Sigfox to ensure accurate location information is available regardless of whether an asset is inside a warehouse, outside in the lot or in transit. Integrating Skyhook’s technology into Sigfox’s global location platform is an important next step as Sigfox maintains its position as a recognized global leader in the IoT space,” said Craig Waggy, CEO of Skyhook.
“This partnership with Skyhook will help our clients gain better visibility of their supply chains, and ultimately provide a better service to their end customers. Understanding the exact location of assets globally without the additional costs associated with new infrastructure will no doubt drive business efficiencies. We see major traction around postal, retail and automotive use cases and Skyhook will help us provide the right quality of services for these key customers,” added Benjamin Mazet, Asset Tracking Director at Sigfox.
******
About Sigfox
Sigfox is a world’s leading IoT (Internet of Things) communication service provider and 0G network pioneer. Sigfox offers a unique combination of ultra-low cost and ultra-low power solutions enabled by a single global network, owned and operated by 75 Sigfox Operators, enabling businesses to gain visibility and track their assets worldwide. With more than 19 million connected devices and 75 million messages sent a day, Sigfox helps its customers to extract data at the lowest cost of production and accelerate their digital transformation in key areas such as asset tracking and monitoring.
ISO 9001 certified and supported by a strong partner ecosystem, Sigfox was founded in 2010 and is headquartered in Labège, France, with offices in Boston, Dallas, Dubai, Madrid, Paris, Sao Paulo, Singapore, and Tokyo.
About Skyhook
Skyhook is the worldwide independent leader in location technology, operating the world's largest independent location network, consisting of over 6 billion geolocated Wi-Fi access points, over 110 million geolocated cells, and 1.5 billion geolocated IP addresses. Skyhook processes tens of billions of location transactions, serving devices, apps, wearables, brands and advertising platforms with precise and accurate location data and intelligence. Skyhook, through its parent company Skyhook Holding, Inc., operates as a wholly owned subsidiary of Liberty Broadband Corporation. To learn more visit www.skyhook.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211209005469/en/
Contact information
Press Contacts
S
igfox
Antoine Mège, Corporate Communications
antoine.mege@sigfox.com
Skyhook
Isolde Decker-Lucke, Marketing Manager
idecker-lucke@skyhook.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
